• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚甲基四氢叶酸还原酶(MTHFR)677C/T 多态性与首发精神分裂症抗精神病药引起的体重增加有关。

Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia.

机构信息

Sheffield Hallam University, Sheffield, UK.

ZhongDa Hospital and SouthEast University, Nanjing, China.

出版信息

Int J Neuropsychopharmacol. 2014 Mar;17(3):485-90. doi: 10.1017/S1461145713001375. Epub 2013 Nov 13.

DOI:10.1017/S1461145713001375
PMID:24229535
Abstract

Genetic variants of the methylenetetrahydrofolate reductase (MTHFR) gene involved in homocysteine metabolism may be important predictors of antipsychotic drug-induced weight gain (AIWG). We tested whether two functional MTHFR polymorphisms are related to AIWG. Weight gain was studied in two cohorts of first-episode, initially drug-naive schizophrenia patients; Chinese Han (n = 182) and Spanish Caucasians (n = 72) receiving antipsychotics for 10 wk and 3 months respectively. Blood DNA was genotyped for 677C/T and 1298A/C MTHFR polymorphisms. Patients with the 677 CC genotype had a significantly greater increase in BMI compared to T-allele carriers in both Chinese (p = 0.012) and Spanish (p = 0.017) samples. The 677C/T MTHFR polymorphism showed an additive effect, but no significant interaction, with the -759C/T HTR2C polymorphism previously associated with AIWG. These results suggest that the 677C/T MTHFR polymorphism might, along with the -759C/T HTR2C polymorphism and other genetic factors, provide a useful marker for the important and limiting side effect of AIWG.

摘要

参与同型半胱氨酸代谢的亚甲基四氢叶酸还原酶(MTHFR)基因的遗传变异可能是抗精神病药引起体重增加(AIWG)的重要预测因子。我们测试了两个功能性 MTHFR 多态性是否与 AIWG 有关。体重增加在两个首次发作、最初未接受药物治疗的精神分裂症患者队列中进行了研究;中国汉族(n = 182)和西班牙白种人(n = 72)分别接受抗精神病药物治疗 10 周和 3 个月。对 677C/T 和 1298A/C MTHFR 多态性进行了血 DNA 基因分型。与 T 等位基因携带者相比,677CC 基因型的患者在中国(p = 0.012)和西班牙(p = 0.017)两个样本中 BMI 的增加明显更大。677C/T MTHFR 多态性显示出累加效应,但与先前与 AIWG 相关的 -759C/T HTR2C 多态性无显著交互作用。这些结果表明,677C/T MTHFR 多态性可能与 -759C/T HTR2C 多态性和其他遗传因素一起,为 AIWG 的重要且限制副作用提供了有用的标志物。

相似文献

1
Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia.亚甲基四氢叶酸还原酶(MTHFR)677C/T 多态性与首发精神分裂症抗精神病药引起的体重增加有关。
Int J Neuropsychopharmacol. 2014 Mar;17(3):485-90. doi: 10.1017/S1461145713001375. Epub 2013 Nov 13.
2
Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances.亚甲基四氢叶酸还原酶基因变异与抗精神病药物所致体重增加及代谢紊乱
J Psychiatr Res. 2014 Jul;54:36-42. doi: 10.1016/j.jpsychires.2014.03.012. Epub 2014 Mar 21.
3
Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.单碳代谢中的遗传变异与首发精神分裂症患者代谢参数的变化。
Int J Neuropsychopharmacol. 2017 Mar 1;20(3):207-212. doi: 10.1093/ijnp/pyw094.
4
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.对接受抗精神病药物治疗的精神分裂症患者进行亚甲基四氢叶酸还原酶(MTHFR)677C/T和1298A/C基因分型,研究其代谢综合征和胰岛素抵抗情况。
Schizophr Res. 2008 Jan;98(1-3):47-54. doi: 10.1016/j.schres.2007.09.030. Epub 2007 Oct 31.
5
Association of the MTHFR gene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia.MTHFR基因与精神分裂症患者抗精神病药物所致代谢异常的关联
Pharmacogenomics. 2012 Jun;13(8):843-6. doi: 10.2217/pgs.12.64.
6
-759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia.5-羟色胺受体2C基因-759C>T多态性与精神分裂症女性患者第二代抗精神病药物所致体重增加相关。
Pharmacopsychiatry. 2017 Jan;50(1):14-18. doi: 10.1055/s-0042-110321. Epub 2016 Jul 14.
7
[Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].抗精神病药物所致体重增加与5-羟色胺2C受体基因启动子区域多态性的关联
Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1097-101.
8
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.ADRA2A和MTHFR基因多态性与抗精神病药物换用阿立哌唑或齐拉西酮后体重减轻的关联。
Hum Psychopharmacol. 2014 Jan;29(1):38-45. doi: 10.1002/hup.2366. Epub 2013 Nov 25.
9
The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.亚甲基四氢叶酸还原酶677C>T和1298A>C基因多态性在烟雾病患者中的作用。
Childs Nerv Syst. 2014 Oct;30(10):1687-95. doi: 10.1007/s00381-014-2495-3. Epub 2014 Aug 7.
10
Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma.亚甲基四氢叶酸还原酶基因多态性c.677C/T和c.1298A/C与开角型青光眼无关。
Mol Vis. 2006 Jul 7;12:735-9.

引用本文的文献

1
Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review).精神分裂症患者的代谢综合征:潜在机制与治疗方法(综述)
Mol Med Rep. 2025 May;31(5). doi: 10.3892/mmr.2025.13479. Epub 2025 Feb 28.
2
Atypical antipsychotic use does not impact weight gain for individuals with extreme anorexia nervosa: a retrospective case-control study.非典型抗精神病药物的使用对患有极端神经性厌食症的个体的体重增加没有影响:一项回顾性病例对照研究。
J Eat Disord. 2023 Dec 6;11(1):215. doi: 10.1186/s40337-023-00941-6.
3
Associations of Genetic Variants of Methylenetetrahydrofolate Reductase and Serum Folate Levels with Metabolic Parameters in Patients with Schizophrenia.
亚甲基四氢叶酸还原酶基因多态性与叶酸水平与精神分裂症患者代谢参数的相关性研究。
Int J Environ Res Public Health. 2021 Oct 28;18(21):11333. doi: 10.3390/ijerph182111333.
4
Association of C677T Polymorphism With Antipsychotic-Induced Change of Weight and Metabolism Index.C677T基因多态性与抗精神病药物所致体重及代谢指标变化的相关性
Front Psychiatry. 2021 May 21;12:673715. doi: 10.3389/fpsyt.2021.673715. eCollection 2021.
5
C677T Polymorphism in the Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia.基因中的C677T多态性与精神分裂症患者中利培酮引起的体重增加有关。
Front Psychiatry. 2020 Jul 2;11:617. doi: 10.3389/fpsyt.2020.00617. eCollection 2020.
6
Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.中国人抗精神病药引起体重增加的药物遗传学相关性研究。
Neurosci Bull. 2019 Jun;35(3):561-580. doi: 10.1007/s12264-018-0323-6. Epub 2019 Jan 3.
7
Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.单碳代谢中的遗传变异与首发精神分裂症患者代谢参数的变化。
Int J Neuropsychopharmacol. 2017 Mar 1;20(3):207-212. doi: 10.1093/ijnp/pyw094.
8
Genetics of Common Antipsychotic-Induced Adverse Effects.常见抗精神病药物所致不良反应的遗传学
Mol Neuropsychiatry. 2016 Jul;2(2):61-78. doi: 10.1159/000445802. Epub 2016 May 20.
9
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.抗精神病药物所致体重增加的药物遗传学关联:一项系统评价和荟萃分析
Schizophr Bull. 2016 Nov;42(6):1418-1437. doi: 10.1093/schbul/sbw058. Epub 2016 May 23.
10
Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.精神分裂症症状及神经认知障碍的当前和新兴治疗方法。
Curr Treat Options Psychiatry. 2015 Jun;1(2):107-120. doi: 10.1007/s40501-014-0010-9.